TMDX
TMDX is being tracked as a sentiment-driven, 'picks-and-shovels' exposure to organ preservation and cryo-infrastructure. A recent social post about Until Labs’ organ-scale rewarming milestone is the primary catalyst informing current coverage.
Recent proof-backed thesis calls
One recommendation: a note highlighting a social post about Until Labs' reversible cryopreservation/rewarming progress (passing the ice-formation 'danger zone' in under a minute on pig-kidney scale). Total recommendations: 1. Open: 0, Previewed: 1, Right: 0, Wrong: 1.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Current stance
Current recommendation: hold. Rationale: exposure is sentiment-driven via a social-media signal tied to a likely private company; the milestone is technology-relevant but lacks a clear commercialization timeline. Confidence: 0.22.
- hold via Sentiment-driven ‘picks-and-shovels’ exposure to organ preservation / cryo-infrastructure from https://x.com/untillabs (confidence 0.22)
Top authors on this asset
Active and historical ticker theses
Active play focuses on short- to mid-term upside from transplant volume growth for organ-preservation infrastructure, with longer-term uncertainty if cryobanking reduces the urgency or the value of rapid transport.
Unlock full asset monitoring
Monitor further technical disclosures or independent validation from Until Labs and any commercial milestones before moving from a hold stance.